Lnc-PINK regulation of innate immunity in lung epithelial cells
Lnc-PINK regulation of innate immunity in lung epithelial cells
批准号:
10365976
负责人:
LIN LIU
金额:
$18.7万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-05 至 2025-02-28
关键词:
Acute Respiratory Distress SyndromeAntiviral AgentsCell physiologyDataDevelopmentDrug TargetingEpidemicEpithelialEpithelial CellsGene ExpressionGoalsHost DefenseHumanInflammasomeIntegration Host FactorsLungMediatingMessenger RNAModelingMolecularMolecular CloningMutationNatural ImmunityNucleotidesPINK1 genePeriodicityPharmacologyPneumoniaProteinsRegulationRespiratory SystemRoleTXNIP geneTestingTherapeutic InterventionTranscriptUntranslated RNAViralViral Drug ResistanceViral ProteinsViral Vaccinesbasedefense responsefirst responderinfluenza infectioninfluenzavirusmortalitynovelpandemic diseaserespiratory infection virusrespiratory pathogenrespiratory virustranscriptome sequencing
中文摘要
项目总结
流感病毒感染呼吸道,可能导致急性呼吸窘迫综合征和
肺炎与高死亡率相关。该项目的长期目标是了解
肺上皮细胞如何响应和限制呼吸道病毒感染的分子机制。先天的
免疫是呼吸道病原体入侵的第一反应者,是人类免疫的第一道防线。
阿龙。从而通过靶向肺上皮宿主来增强宿主对呼吸道病毒的防御反应
因子是一种无论病毒发生任何变化都限制呼吸道病毒感染的策略。长非编码
RNAs(LncRNAs)是一种与mRNAs类似的转录产物,其大小为200个核苷酸,但不编码蛋白质
并参与多种细胞过程,包括先天免疫。通过RNA测序分析
和分子克隆,我们已经在肺上皮细胞中鉴定出一种新的lncRNA转录本,lnc-PINK1-2:5
减少流感病毒感染并上调硫氧还蛋白相互作用蛋白(TXNIP)的表达
这会激活NLRP3炎症。基于这一初步数据,我们假设LNC-PINK1-2:5
上调TXNIP基因激活NLRP3炎性小体抑制呼吸道病毒感染
在肺上皮细胞中表达。目的确定lnc-PINK1-2:5在流感病毒中的功能作用。
人肺上皮细胞感染。AIM II将阐明lnc-PINK1-2:5-的分子机制
流感病毒在人肺上皮细胞中的介导限制。
英文摘要
PROJECT SUMMARY
The influenza virus infects the respiratory tract and may result in acute respiratory distress syndrome and
pneumonia associated with a high mortality rate. The long-term goal of this project is to understand the
molecular mechanisms how the lung epithelial cells responds to and restricts respiratory virus infection. Innate
immunity is the first responder to respiratory pathogen invasion and provides the first line of defense in the
lung. Thus enhancing the host defense response against respiratory virus by targeting lung epithelial host
factors is a strategy to restrict respiratory virus infection regardless of any viral changes. Long non-coding
RNAs (lncRNAs) are mRNA-like transcripts with a size of > 200 nucleotides, but that do not encode proteins
and are involved in diverse cellular processes including innate immunity. Through RNA sequencing analysis
and molecular cloning, we have identified a novel lncRNA transcript, lnc-PINK1-2:5 in lung epithelial cells that
reduces influenza virus infection and up-regulates the expression of thioredoxin interacting protein (TXNIP)
that activates NLRP3 inflammasomses. Based on this preliminary data, we hypothesized that lnc-PINK1-2:5
restricts respiratory virus infection by activating NLRP3 inflammasomes via upregulating TXNIP gene
expression in lung epithelial cells. Aim I will establish the functional roles of lnc-PINK1-2:5 in influenza virus
infection of human lung epithelial cells. Aim II will delineate the molecular mechanisms of lnc-PINK1-2:5-
mediated restriction of influenza virus in human lung epithelial cells.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1159/000532063
发表时间:
2023
期刊:
Journal of innate immunity
影响因子:
5.3
作者:
[]
通讯作者:
DOI:
10.1080/15476286.2023.2241755
发表时间:
2023-01
期刊:
RNA BIOLOGY
影响因子:
4.1
作者:
[Pushparaj, Samuel, Gandikota, Chaitanya, Vaddadi, Kishore, Liang, Yurong, Liu, Lin]
通讯作者:
Liu, Lin
DOI:
10.1111/jcmm.17249
发表时间:
2022-04
期刊:
Journal of cellular and molecular medicine
影响因子:
5.3
作者:
[Pushparaj S, Zhu Z, Huang C, More S, Liang Y, Lin K, Vaddadi K, Liu L]
通讯作者:
Liu L
DOI:
10.1111/mmi.14995
发表时间:
2022-12
期刊:
MOLECULAR MICROBIOLOGY
影响因子:
3.6
作者:
[Guo, Yujie, Bamunuarachchi, Gayan, Vaddadi, Kishore, Zhu, Zhengyu, Gandikota, Chaitanya, Ahmed, Kainat, Pushparaj, Samuel, More, Sunil, Xiao, Xiao, Yang, Xiaoyun, Liang, Yurong, Mukherjee, Sanjay, Baviskar, Pradyumna, Huang, Chaoqun, Li, Shitao, Oomens, Antonius G. P., Metcalf, Jordan Patrick, Liu, Lin]
通讯作者:
Liu, Lin
Pilot Project Grant Program
-
批准号:10628217
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2023
-
负责人:LIN LIU
-
依托单位:
Oklahoma Center for Respiratory and Infectious Diseases
-
批准号:10628212
-
项目类别:
-
资助金额:$110.11万
-
财政年份:2023
-
负责人:LIN LIU
-
依托单位:
Administrative Core
-
批准号:10628213
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2023
-
负责人:LIN LIU
-
依托单位:
The Role of Iron In Pulmonary Fibrosis
-
批准号:10838699
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2023
-
负责人:LIN LIU
-
依托单位:
Molecular Biology Core
-
批准号:10628216
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2023
-
负责人:LIN LIU
-
依托单位:
The Role of Iron In Pulmonary Fibrosis
-
批准号:10586471
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2022
-
负责人:LIN LIU
-
依托单位:
Oklahoma Center for Respiratory and Infectious Diseases
-
批准号:10215542
-
项目类别:
-
资助金额:$223.38万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Molecular Biology Core
-
批准号:10459262
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Oklahoma Center for Respiratory and Infectious Diseases
-
批准号:8686887
-
项目类别:
-
资助金额:$218.87万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Administrative Core
-
批准号:10215543
-
项目类别:
-
资助金额:$119.34万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
miR-101 Control of Pulmonary Fibrosis
-
批准号:9066199
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
miR-101 Control of Pulmonary Fibrosis
-
批准号:8579316
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
miR-101 Control of Pulmonary Fibrosis
-
批准号:8847381
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Oklahoma Center for Respiratory and Infectious Diseases
-
批准号:10459258
-
项目类别:
-
资助金额:$223.62万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Administrative Core
-
批准号:10459259
-
项目类别:
-
资助金额:$89.81万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Oklahoma Center for Respiratory and Infectious Diseases
-
批准号:8432246
-
项目类别:
-
资助金额:$247.66万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Molecular Biology Core
-
批准号:10215546
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2013
-
负责人:LIN LIU
-
依托单位:
Role of MicroRNAs in Bronchopulmonary Dysplasia
-
批准号:7844899
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2009
-
负责人:LIN LIU
-
依托单位:
MicroRNA Expression Profiling in Idiopathic Pulmonary Fibrosis
-
批准号:7708091
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2009
-
负责人:LIN LIU
-
依托单位:
MicroRNA Expression Profiling in Idiopathic Pulmonary Fibrosis
-
批准号:7837598
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2009
-
负责人:LIN LIU
-
依托单位:
海外基金